SAMANTHA GOODLETT: Open Payments
NPI 1730850363 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 134 payments from 18 companies in 2025. Trend: 2023 $1,582 · 2024 $2,002 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $252 |
| Axsome Therapeutics, Inc. | 13 | $232 |
| Vanda Pharmaceuticals Inc. | 14 | $224 |
| ABBVIE INC. | 16 | $215 |
| E.R. Squibb & Sons, L.L.C. | 12 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $198 |
| Janssen Pharmaceuticals, Inc | 6 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $154 |
| Alkermes, Inc. | 8 | $145 |
| Neurocrine BioSciences, Inc. | 5 | $88 |
Products named: Auvelity, FANAPT, VRAYLAR, COBENFY, CAPLYTA, REXULTI, TRINTELLIX, LYBALVI.
Industry payments across KY — which companies pay providers there.
